Adriana Romiti

Summary

Country: Italy

Publications

  1. ncbi A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Silverio Tomao
    Department of Clinical Oncology, Regina Elena Cancer Institute of Rome, Via Chianesi, 53, 00100 Rome, Italy
    BMC Cancer 6:137. 2006
  2. ncbi Gastric mucosa alterations in first-degree relatives of gastric cancer patients
    Adriana Romiti
    Oncology, Sant Andrea Hospital, Rome, Italy
    Anticancer Res 25:2567-72. 2005
  3. ncbi Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma
    Adriana Romiti
    Department of Oncology, Sant Andrea Hospital, La Sapienza University, Via Grottarossa 1035, 00189, Rome, Italy
    Anticancer Res 32:115-9. 2012
  4. ncbi Relationship between beta-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia
    Adriana Romiti
    Medical Oncology, Sant Andrea Hospital, Rome, Italy
    World J Gastroenterol 11:4400-3. 2005
  5. ncbi Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study
    Angelo Zullo
    Department of Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy
    Eur J Gastroenterol Hepatol 18:921-6. 2006
  6. ncbi Alteration of E-cadherin expression in gastric mucosa: role of intestinal metaplasia and Helicobacter pylori infection
    Angelo Zullo
    Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy
    Anticancer Res 24:1603-7. 2004
  7. ncbi Chemotherapy for the biliary tract cancers: moving toward improved survival time
    Adriana Romiti
    Department of Oncology, Sant Andrea Hospital, La Sapienza University, Rome, Italy
    J Gastrointest Cancer 43:396-404. 2012
  8. ncbi Tumors of ampulla of Vater: A case series and review of chemotherapy options
    Adriana Romiti
    Adriana Romiti, Viola Barucca, Ida Sarcina, Roberta Di Rocco, Chiara D Antonio, Paolo Marchetti, Oncology Unit, University La Sapienza, Sant Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy
    World J Gastrointest Oncol 4:60-7. 2012
  9. ncbi Long-term survival in metastatic pancreatic cancer. A case report and review of the literature
    Gian Paolo Spinelli
    Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy
    JOP 7:486-91. 2006
  10. ncbi Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer
    Adriana Romiti
    National Cancer Institute of Genoa, Section of Rome, Department of Experimental Medicine and Pathology, La Sapienza University of Rome, Rome, Italy
    Anticancer Res 22:3071-6. 2002

Collaborators

  • Silverio Tomao
  • Cesare Hassan
  • A Zullo
  • B Vincenzi
  • Francesco Recchia
  • Luca Messerini
  • S Cascinu
  • E Ierardi
  • D Santini
  • Luigi Rossi
  • Viola Barucca
  • Roberto Valente
  • Marisa Di Seri
  • Francesco Di Costanzo
  • Gian Paolo Spinelli
  • Matteo Piciucchi
  • Elsa Iannicelli
  • Marcella Mottolese
  • Federica Zoratto
  • Maria Falchetto Osti
  • Diana Giannarelli
  • Paola Pierantognetti
  • Giulia Francesca Federici
  • Emilio Di Giulio
  • Paolo Mercantini
  • Gabriele Capurso
  • Maria Colonna
  • Vincenzo Ziparo
  • Luigi Ruco
  • Alberto Larghi
  • Gianfranco Delle Fave
  • Flavia Longo
  • Enzo Veltri
  • Daniela Adua
  • Giancarlo Bisagni
  • Rodolfo Canaletti
  • Gabriele Luppi
  • Maurizio Tonato
  • Giovanni Natalini
  • Franco Figoli
  • Mario Trignano
  • Loreto Scipioni
  • Angelo Olgiati
  • Alessandro Cabassi
  • Alessandra Olivetti
  • Rossella Rovei
  • Maurizio Cesari
  • Gianfranco Orselli
  • Lorenzo Bruno
  • Carla Cavalli
  • Maria Ruggeri Enzo
  • Giorgio Papiani
  • Giuseppe Fornarini
  • Angelo Nicolosi
  • Umberto Pandolfi
  • Paolo Carlini
  • Riccardo Rossetti
  • Raffaella Bracci
  • Diletta Bianchini
  • Maurizio Leoni
  • Corrado Boni
  • Antonio Muscogiuri
  • Vincenzo Catalano
  • Manlio Carboni
  • Vincenzo Bellini
  • Federica Di Costanzo
  • Gennaro Strafiuso
  • Annarosa Arcangeli
  • Mario Frignano
  • Franco Biagioni
  • Angelo Dalla Mola
  • Micol Mela
  • Sabina Oldani
  • Andrea Piga
  • Fabrizio Nelli
  • Maria Teresa Ionta
  • Maria Giuseppina Sarobba
  • Enrico Cortesi
  • Antonio Contu
  • Salvatore Camera
  • Mauro Antimi
  • Roberto Labianca
  • Silvia Gasperoni
  • Ermanno Rondini
  • Maurizio Italia
  • Marinella De Stefanis
  • Ferdinando Lungarotti
  • Giuseppina Catalano
  • Fausto Grigniani
  • Stella Porrozzi

Detail Information

Publications13

  1. ncbi A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Silverio Tomao
    Department of Clinical Oncology, Regina Elena Cancer Institute of Rome, Via Chianesi, 53, 00100 Rome, Italy
    BMC Cancer 6:137. 2006
    ..Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed and metastatic disease after failure of chemotherapy with antracyclines...
  2. ncbi Gastric mucosa alterations in first-degree relatives of gastric cancer patients
    Adriana Romiti
    Oncology, Sant Andrea Hospital, Rome, Italy
    Anticancer Res 25:2567-72. 2005
    ..On the other hand, both gastric cell hyperproliferation and abnormalities of adhesion molecules have been involved in gastric carcinogenesis. We studied gastric mucosa alterations in first-degree relatives of gastric cancer patients...
  3. ncbi Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma
    Adriana Romiti
    Department of Oncology, Sant Andrea Hospital, La Sapienza University, Via Grottarossa 1035, 00189, Rome, Italy
    Anticancer Res 32:115-9. 2012
    ..This study assessed the presence of somatostatin receptor subtype 2A (SSTR2A) in gastric cancer, correlating its expression with histological type, grade, human epidermal growth factor receptor 2 (HER2) expression, and disease outcome...
  4. ncbi Relationship between beta-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia
    Adriana Romiti
    Medical Oncology, Sant Andrea Hospital, Rome, Italy
    World J Gastroenterol 11:4400-3. 2005
    ..To investigate beta-catenin expression in patients with intestinal metaplasia, and to look for a possible relationship between beta-catenin expression and either epithelial proliferation values or Helicobacter pylori (H pylori) infection...
  5. ncbi Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study
    Angelo Zullo
    Department of Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy
    Eur J Gastroenterol Hepatol 18:921-6. 2006
    ..Individuals with a family history of gastric cancer have an increased risk of developing such neoplasia. This study aimed to assess epithelial cell proliferation and ras oncogene mutation in such individuals...
  6. ncbi Alteration of E-cadherin expression in gastric mucosa: role of intestinal metaplasia and Helicobacter pylori infection
    Angelo Zullo
    Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, Rome, Italy
    Anticancer Res 24:1603-7. 2004
    ..This study aimed to assess the role of both intestinal metaplasia and H. pylori infection on E-cadherin expression in gastric mucosa...
  7. ncbi Chemotherapy for the biliary tract cancers: moving toward improved survival time
    Adriana Romiti
    Department of Oncology, Sant Andrea Hospital, La Sapienza University, Rome, Italy
    J Gastrointest Cancer 43:396-404. 2012
    ..Although encouraging data emerged with the use of targeted therapies, further efforts are needed to improve treatment options for patients with biliary tract cancer...
  8. ncbi Tumors of ampulla of Vater: A case series and review of chemotherapy options
    Adriana Romiti
    Adriana Romiti, Viola Barucca, Ida Sarcina, Roberta Di Rocco, Chiara D Antonio, Paolo Marchetti, Oncology Unit, University La Sapienza, Sant Andrea Hospital, Via di Grottarossa 1035, 00189 Rome, Italy
    World J Gastrointest Oncol 4:60-7. 2012
    ..In accordance with the literature, a longer median survival was observed in the group of ampullary carcinomas...
  9. ncbi Long-term survival in metastatic pancreatic cancer. A case report and review of the literature
    Gian Paolo Spinelli
    Department of Experimental Medicine and Pathology, La Sapienza University, Rome, Italy
    JOP 7:486-91. 2006
    ..DISCUSSION: This is the fifth case reported in the literature showing that long-term survival may be achieved even in advanced pancreatic cancer...
  10. ncbi Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer
    Adriana Romiti
    National Cancer Institute of Genoa, Section of Rome, Department of Experimental Medicine and Pathology, La Sapienza University of Rome, Rome, Italy
    Anticancer Res 22:3071-6. 2002
    ..In this retrospective study, the tolerability of raltitrexed in patients with CRC was examined in relation to age...
  11. ncbi Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice
    Luigi Rossi
    Oncology, S M Goretti Hospital, Latina, Sapienza University, Rome, Italy
    Future Oncol 8:1193-7. 2012
    ..We aimed to evaluate the overall clinical response to such a therapy in clinical practice and assess the role of KRAS status on therapy response...
  12. ncbi Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy
    Roberto Valente
    Roberto Valente, Gabriele Capurso, Matteo Piciucchi, Emilio Di Giulio, Gianfranco Delle Fave, Digestive and Liver Disease Unit, Second Medical School, La Sapienza University, S Andrea Hospital, 00189 Rome, Italy
    World J Gastrointest Oncol 4:22-5. 2012
    ..This is also the first reported case of IPMN-B successfully treated with chemoradiotherapy. Clinicians should consider medical treatment as an option in this clinical scenario, in patients who may be unfit for surgery...
  13. ncbi Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC
    Francesco Di Costanzo
    Unit of Medical Oncology, Azienda Ospedaliero Universitaria Careggi, Viale Pieraccini 17, 50139 Florence, Italy
    J Natl Cancer Inst 100:388-98. 2008
    ..Complete surgical resection of gastric cancer is potentially curative, but long-term survival is poor...